Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - FATE THERAPEUTICS INC | Financial_Report.xls |
10-K - 10-K - FATE THERAPEUTICS INC | a2223519z10-k.htm |
EX-31.1 - EX-31.1 - FATE THERAPEUTICS INC | a2223519zex-31_1.htm |
EX-32.1 - EX-32.1 - FATE THERAPEUTICS INC | a2223519zex-32_1.htm |
EX-23.1 - EX-23.1 - FATE THERAPEUTICS INC | a2223519zex-23_1.htm |
EX-31.2 - EX-31.2 - FATE THERAPEUTICS INC | a2223519zex-31_2.htm |
EX-10.25 - EX-10.25 - FATE THERAPEUTICS INC | a2223519zex-10_25.htm |
EX-10.24 - EX-10.24 - FATE THERAPEUTICS INC | a2223519zex-10_24.htm |
EX-10.26 - EX-10.26 - FATE THERAPEUTICS INC | a2223519zex-10_26.htm |
EX-10.23 - EX-10.23 - FATE THERAPEUTICS INC | a2223519zex-10_23.htm |
QuickLinks -- Click here to rapidly navigate through this document
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, J. Scott Wolchko, Chief Financial Officer of Fate Therapeutics, Inc. (the "Registrant"), do hereby certify in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based upon my knowledge:
- (1)
- this
Annual Report on Form 10-K of the Registrant, to which this certification is attached as an exhibit (the "Report"), fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and
- (2)
- the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
Date:
March 12, 2015
|
/s/ J. SCOTT WOLCHKO J. Scott Wolchko Chief Financial Officer and Chief Operating Officer |
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002